Company Filing History:
Years Active: 2006-2012
Title: The Innovations of Petri Vainio
Introduction
Petri Vainio is a notable inventor based in Turku, Finland. He has made significant contributions to the field of biomedical research, particularly in the development of therapeutic antibodies. With a total of 3 patents to his name, Vainio's work focuses on innovative methods for treating inflammatory conditions.
Latest Patents
Vainio's latest patents include groundbreaking methods of treating inflammatory conditions involving VAP-1-mediated adhesion with VAP-1-specific antibodies. These patents disclose novel fully human anti-VAP-1 antibodies and fragments thereof. Additionally, they cover nucleic acids encoding these antibodies, as well as expression vectors and host cells that facilitate the recombinant expression of anti-VAP-1 antibodies. The patents also detail pharmaceutical compositions comprising these antibodies and their therapeutic uses. Another significant patent involves fully human anti-VAP-1 monoclonal antibodies, further emphasizing Vainio's commitment to advancing medical treatments.
Career Highlights
Petri Vainio is associated with Biotie Therapies Corporation, where he continues to innovate in the field of therapeutic antibodies. His work has the potential to impact the treatment of various inflammatory conditions, showcasing his dedication to improving patient outcomes.
Collaborations
Vainio has collaborated with notable colleagues, including David Smith and Jari Mikkola, to further enhance his research and development efforts.
Conclusion
Petri Vainio's contributions to the field of biomedical research through his patents and collaborations highlight his role as an influential inventor. His work in developing anti-VAP-1 antibodies represents a significant advancement in therapeutic options for inflammatory conditions.